# Renovo clinical trials: 30 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials with Renovo as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Renovo: 30 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/renovo

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 4, 2010 | NCT01115868 | Prevascar in African Continental Group Scarring | Renovo | Phase 1 | Unknown | Scarring | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01115868) |
| December 9, 2009 | NCT01029158 | A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo | Renovo | Phase 1 | Completed | Scar Improvement | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01029158) |
| November 17, 2009 | NCT01014494 | Adaprev in Digital Flexor Tendon Repair | Renovo | Not applicable | Unknown | Tendon Injuries | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01014494) |
| September 25, 2009 | NCT00984854 | Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects | Renovo | Phase 1 | Completed | Cicatrix, Re-epithelialisation | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984854) |
| September 25, 2009 | NCT00984646 | Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10) | Renovo | Phase 2 | Completed | Cicatrix, Wound Healing | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984646) |
| September 25, 2009 | NCT00984581 | Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects | Renovo | Phase 1/2 | Completed | Cicatrix, Wound Healing | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984581) |
| September 25, 2009 | NCT00984516 | Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times | Renovo | Phase 2 | Completed | Cicatrix, Wound-healing | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984516) |
| September 25, 2009 | NCT00984503 | Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites | Renovo | Phase 2 | Completed | Cicatrix, Wound Healing | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984503) |
| September 25, 2009 | NCT00984386 | Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing | Renovo | Phase 2 | Completed | Cicatrix, Wound-healing | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00984386) |
| September 16, 2009 | NCT00978367 | Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista) | Renovo | Phase 1/2 | Completed | Cicatrix, Wound Healing, Re-epithelialization | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00978367) |
| September 16, 2009 | NCT00978302 | Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista) | Renovo | Phase 1 | Completed | Cicatrix, Wound Healing | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00978302) |
| September 16, 2009 | NCT00977951 | Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects | Renovo | Phase 1/2 | Completed | Cicatrix, Wound Healing | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00977951) |
| February 19, 2009 | NCT00847925 | Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects | Renovo | Phase 1/2 | Completed | Cicatrix | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00847925) |
| February 19, 2009 | NCT00847795 | Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects. | Renovo | Phase 1/2 | Completed | Cicatrix | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00847795) |
| February 4, 2009 | NCT00836147 | Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids | Renovo | Phase 1/2 | Completed | Keloid | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00836147) |
| January 13, 2009 | NCT00821457 | Juvista in the Non-surgical Improvement of Existing Scars | Renovo | Not applicable | Withdrawn | Scars | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00821457) |
| August 27, 2008 | NCT00742443 | Juvista in Scar Revision Surgery of Disfiguring Scars | Renovo | Phase 3 | Completed | Cicatrix | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00742443) |
| July 4, 2008 | NCT00710333 | Safety of Juvista When Administered Following Excision of Ear Lobe Keloids | Renovo | Phase 1/2 | Completed | Keloid | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00710333) |
| April 22, 2008 | NCT00664352 | Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites | Renovo | Phase 1/2 | Completed | Wound | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00664352) |
| April 22, 2008 | NCT00663780 | Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082 | Renovo | Observational | Completed | Wound | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00663780) |
| April 11, 2008 | NCT00656227 | A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision | Renovo | Phase 2 | Unknown | Nevus, Cicatrix | 239 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00656227) |
| March 6, 2008 | NCT00629811 | Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women | Renovo | Phase 2 | Completed | Cicatrix | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00629811) |
| March 3, 2008 | NCT00627536 | Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin... | Renovo | Phase 2 | Completed | Cicatrix | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00627536) |
| January 15, 2008 | NCT00594581 | Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males | Renovo | Phase 2 | Completed | Cicatrix | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00594581) |
| May 4, 2007 | NCT00469235 | Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars | Renovo | Phase 1/2 | Completed | Keloid | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00469235) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 4 |
| Phase 1/2 | 9 |
| Phase 2 | 12 |
| Phase 3 | 2 |
| Not applicable | 2 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Unknown | 4 |
| Withdrawn | 1 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cicatrix | 22 |
| Wounds and Injuries | 3 |
| Keloid | 3 |
| Arrhythmogenic Right Ventricular Dysplasia, Familial, 1 | 2 |
| Varicose Veins | 1 |
| Nevus | 1 |
| Tendon Injuries | 1 |
| Burns | 1 |
| Varicose Ulcer | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Marble and granite professional companies in the United States](https://specstream.ai/data/businesses/marble-and-granite-professional-companies/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
- [Blueprint printers in the United States](https://specstream.ai/data/businesses/blueprint-printers/united-states)
- [Generator installation repair companies in the United States](https://specstream.ai/data/businesses/generator-installation-repair-companies/united-states)
- [Pediatric oncology practices in the United States](https://specstream.ai/data/businesses/pediatric-oncology-practices/united-states)
- [Welding companies in the United States](https://specstream.ai/data/businesses/welding-companies/united-states)
